Enhancement Strategies for Therapeutic Antibodies

Enhancing the avidity of mAbs would enable more effective therapies to be created - broadening the number of patients considered suitable for treatment and raising the possibility of resurrecting compounds that have failed in clinical development

Jeff Morhet (May 2008)

Keywords: Making mAbs better, Enhancing avidity, resurrecting compounds that failed in clinical development

View full article    |    Back to Biopharma section